BLASTP 2.2.26 [Sep-21-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.


Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= 043577
         (402 letters)

Database: pdbaa 
           62,578 sequences; 14,973,337 total letters

Searching..................................................done



>pdb|4II5|B Chain B, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
 pdb|4II5|D Chain D, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
           Ion
          Length = 258

 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M R Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 7   DIHTYLR---EMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 109

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 110 DTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGELSLID 169

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PSLIA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 170 ADPYLKYLPSLIAGAAFHLALYTV--TGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 227

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 228 PQHAQQSIREKYKHSK 243


>pdb|4I3Z|B Chain B, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
 pdb|4I3Z|D Chain D, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
           IONS
          Length = 257

 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M R Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 7   DIHTYLR---EMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 109

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 110 DTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGELSLID 169

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PSLIA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 170 ADPYLKYLPSLIAGAAFHLALYTV--TGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 227

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 228 PQHAQQSIREKYKHSK 243


>pdb|3QHR|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHR|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|B Chain B, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
 pdb|3QHW|D Chain D, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
          Length = 261

 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M R Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 10  DIHTYLR---EMEVKCKPKVGYMKR-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 65

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 66  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 112

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 113 DTYSKKQVLRMEHLVLKVLAFDLAAPTVNQFLTQYFLHLQPANCKVESLAMFLGELSLID 172

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PSLIA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 173 ADPYLKYLPSLIAGAAFHLALYTV--TGQSWPESLAQQTGYTLESLKPCLVDLHQTYLKA 230

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 231 PQHAQQSIREKYKHSK 246


>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
 pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 131/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|3DDQ|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
 pdb|3DDQ|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Roscovitine
          Length = 269

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|3DDP|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
 pdb|3DDP|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Cr8
          Length = 268

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|3BHT|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHT|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 3
 pdb|3BHU|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHU|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           WITH THE Inhibitor Meriolin 5
 pdb|3BHV|B Chain B, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3BHV|D Chain D, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
           With The Inhibitor Variolin B
 pdb|3MY5|B Chain B, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3MY5|D Chain D, Cdk2CYCLINA IN COMPLEX WITH DRB
 pdb|3TNW|B Chain B, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
 pdb|3TNW|D Chain D, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
          Length = 262

 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|3DOG|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
 pdb|3DOG|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           Complex With The Inhibitor N-&-N1
          Length = 264

 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
 pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
           COMPLEX WITH THE Inhibitor Nu6271
          Length = 262

 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|1VIN|A Chain A, Bovine Cyclin A3
          Length = 268

 Score =  134 bits (337), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 132/256 (51%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NTRFIRAAQRSNK-----------APSM-QF---------------ECLANYILELSLLD 327
           +T   +   R              AP++ QF               E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLVQKTGYTLETLKPCLLDLHQTYLRA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
           With A
           2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
           aminopyrimidine Inhibitor
 pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
 pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
           H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
 pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
 pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
           With A Bisanilinopyrimidine Inhibitor
          Length = 260

 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 9   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 64

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 65  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 111

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 112 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 171

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 172 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 229

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 230 PQHAQQSIREKYKNSK 245


>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 261

 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 10  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 65

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 66  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 112

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 113 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 172

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 173 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 230

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 231 PQHAQQSIREKYKNSK 246


>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
 pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
           Its Active Site
          Length = 256

 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 5   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 60

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 61  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 107

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 108 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 167

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 168 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 225

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 226 PQHAQQSIREKYKNSK 241


>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
 pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
           SUBSTRATE
 pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu2058
 pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6094
 pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6086
 pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
           With The Inhibitor Nu6102
 pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
           Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
 pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
           Cdk2CYCLIN A
 pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
           Triazolopyrimidine Inhibitor
 pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
           Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
           A Structure
 pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
           A Peptide Containing Both The Substrate And Recruitment
           Sites Of Cdc6
 pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
           Thiazolidinone Inhibitor
 pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With Atp
 pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Nu6102
 pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With Atp
 pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
           Cyclin A3 Complex With The Inhibitor Ro3306
 pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With Atp
 pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
           Complex With The Inhibitor Ro3306
 pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With Atp
 pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Nu6102
 pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
 pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
           With The Inhibitor Ro3306
          Length = 258

 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 7   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 109

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 110 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 169

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 170 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 227

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 228 PQHAQQSIREKYKNSK 243


>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
 pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
           Peptide From E2f
 pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From Retinoblastoma-Associated Protein
 pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P53
 pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
           Peptide From P27
 pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
           Peptide From P107
 pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
           Groove Inhibitors
 pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
 pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
           Of Peptide Ligands For The Recruitment Site Of Cyclin A
          Length = 259

 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 8   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 63

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 64  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 110

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 111 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 170

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 171 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 228

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 229 PQHAQQSIREKYKNSK 244


>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
 pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
 pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
 pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
 pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
 pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
           Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
           Carboxylic Acid
 pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
           Identification Of Pha-793887, A Potent Cdk Inhibitor
           Suitable For Intravenous Dosing
 pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
 pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
           Quinazoline-3-Carboxamide Inhibitor
          Length = 265

 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 14  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 69

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 70  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 116

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 117 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 176

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 177 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 234

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 235 PQHAQQSIREKYKNSK 250


>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
 pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
 pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
           Inhibitor
 pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Ile-Phe-Nh2
 pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
           Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
 pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
 pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
           H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
 pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
 pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
           Cdk2 Provides Insights For Drug Design
 pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
           Substrate Peptide Derived From Cdc Modified With A
           Gamma- Linked Atp Analogue
 pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
           INHIBITOR
 pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
 pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
 pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
 pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
           Cyclin A Through Structure Guided Design
          Length = 260

 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 9   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 64

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 65  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 111

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 112 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 171

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 172 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 229

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 230 PQHAQQSIREKYKNSK 245


>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
 pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
           The Inhibitor Indirubin-5-Sulphonate Bound
          Length = 261

 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 7   DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 62

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 63  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 109

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 110 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 169

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IA +A  LA + +    + W  +L   T Y    L  C+  LH+ +   
Sbjct: 170 ADPYLKYLPSVIAGAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPCLMDLHQTYLKA 227

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 228 PQHAQQSIREKYKNSK 243


>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y       C+  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLIRKTGYTLETSKPCMLDLHQTYLKA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|4BCQ|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
           2-amino-4- Heteroaryl-pyrimidine Inhibitor
          Length = 262

 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 95/256 (37%), Positives = 130/256 (50%), Gaps = 47/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DI+  LR   + + K +P + +M + Q DI   MRAIL+DWLVEV EEY+L  ETL LAV
Sbjct: 11  DIHTYLR---EMEVKCKPKVGYMKK-QPDITNSMRAILVDWLVEVGEEYKLQNETLHLAV 66

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           NYIDR+LS   ++R +LQL+G A M+++             SK+EEI PP+V E  YITD
Sbjct: 67  NYIDRFLSSMSVLRGKLQLVGTAAMLLA-------------SKFEEIYPPEVAEFVYITD 113

Query: 295 NT-----------------RFIRAAQRSNKAPSMQF----------ECLANYILELSLLD 327
           +T                  F  AA   N+  +  F          E LA ++ ELSL+D
Sbjct: 114 DTYTKKQVLRMEHLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKVESLAMFLGELSLID 173

Query: 328 Y-KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHRLFCDG 386
               L Y PS+IAA+A  LA + +    + W  +L   T Y    L   +  LH+ +   
Sbjct: 174 ADPYLKYLPSVIAAAAFHLALYTV--TGQSWPESLIRKTGYTLESLKPMLLDLHQTYLKA 231

Query: 387 GLSNLSAIREKYSQHK 402
                 +IREKY   K
Sbjct: 232 PQHAQQSIREKYKNSK 247


>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
          Length = 260

 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/262 (32%), Positives = 134/262 (51%), Gaps = 48/262 (18%)

Query: 169 CATIACDIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPE 228
           C+    DIY  LR  E+ QA +   L     + +++   MRAILIDWLV+V  ++RL+ E
Sbjct: 1   CSEYVKDIYAYLRQLEEEQAVRPKYL-----LGREVTGNMRAILIDWLVQVQMKFRLLQE 55

Query: 229 TLFLAVNYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEE 288
           T+++ V+ IDR++  N + ++ LQL+GV  M             ++ SKYEE+ PP++ +
Sbjct: 56  TMYMTVSIIDRFMQNNCVPKKMLQLVGVTAM-------------FIASKYEEMYPPEIGD 102

Query: 289 LCYITDNT-----------RFIRA-------------AQRSNKAPSMQFE--CLANYILE 322
             ++TDNT           + +RA              +R++K   +  E   LA Y++E
Sbjct: 103 FAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLME 162

Query: 323 LSLLDYKMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHR- 381
           L++LDY M+ + PS IAA A  LA  IL      W  TL HY  Y    L   ++ L + 
Sbjct: 163 LTMLDYDMVHFPPSQIAAGAFCLALKILD--NGEWTPTLQHYLSYTEESLLPVMQHLAKN 220

Query: 382 -LFCDGGLSNLSAIREKYSQHK 402
            +  + GL+    ++ KY+  K
Sbjct: 221 VVMVNQGLTKHMTVKNKYATSK 242


>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
 pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
          Length = 269

 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 83/256 (32%), Positives = 131/256 (51%), Gaps = 48/256 (18%)

Query: 175 DIYKNLRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAV 234
           DIY  LR  E  QA +   L     + +++   MRAILIDWLV+V  ++RL+ ET+++ V
Sbjct: 9   DIYAYLRQLEAAQAVRPKYL-----LGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTV 63

Query: 235 NYIDRYLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITD 294
           + IDR++  N + ++ LQL+GV  M             ++ SKYEE+ PP++ +  ++TD
Sbjct: 64  SIIDRFMQNNSVPKKMLQLVGVTAM-------------FIASKYEEMYPPEIGDFAFVTD 110

Query: 295 NT-----------RFIRA-------------AQRSNKAPSMQFE--CLANYILELSLLDY 328
           NT           + +RA              +R++K   +  E   LA Y++EL++LDY
Sbjct: 111 NTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYLMELTMLDY 170

Query: 329 KMLCYSPSLIAASATFLANFILYPLKKPWNSTLGHYTFYQPSDLCDCVKALHR--LFCDG 386
            M+ + PS IAA A  LA  IL      W  TL HY  Y    L   ++ L +  +  + 
Sbjct: 171 DMVHFPPSQIAAGAFSLALKILD--NGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQ 228

Query: 387 GLSNLSAIREKYSQHK 402
           GL+    ++ KY+  K
Sbjct: 229 GLTKHMTVKNKYATSK 244


>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
 pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 271

 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 44/117 (37%), Positives = 63/117 (53%), Gaps = 13/117 (11%)

Query: 180 LRASEDFQAKKRPSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDR 239
           LRA    +    PS+ +   VQK++ P MR I+  W++EV EE +   E   LA+NY+DR
Sbjct: 28  LRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDR 87

Query: 240 YLSGNVIIRQQLQLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITDNT 296
           +LS   + + +LQLLG  CM             +V SK +E  P   E+LC  TDN+
Sbjct: 88  FLSLEPVKKSRLQLLGATCM-------------FVASKMKETIPLTAEKLCIYTDNS 131


>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
          Length = 257

 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 41/105 (39%), Positives = 59/105 (56%), Gaps = 13/105 (12%)

Query: 192 PSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNVIIRQQL 251
           PS+ +   VQK++ P MR I+  W++EV EE +   E   LA+NY+DR+LS   + + +L
Sbjct: 26  PSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRL 85

Query: 252 QLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITDNT 296
           QLLG  CM             +V SK +E  P   E+LC  TDN+
Sbjct: 86  QLLGATCM-------------FVASKMKETIPLTAEKLCIYTDNS 117


>pdb|3G33|B Chain B, Crystal Structure Of Cdk4CYCLIN D3
 pdb|3G33|D Chain D, Crystal Structure Of Cdk4CYCLIN D3
          Length = 306

 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 56/104 (53%), Gaps = 13/104 (12%)

Query: 192 PSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNVIIRQQL 251
           P   +   VQ++I P MR +L  W++EV EE R   E   LA+NY+DRYLS     + QL
Sbjct: 54  PRASYFQCVQREIKPHMRKMLAYWMLEVCEEQRCEEEVFPLAMNYLDRYLSCVPTRKAQL 113

Query: 252 QLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYITDN 295
           QLLG  CM+++             SK  E  P  +E+LC  TD+
Sbjct: 114 QLLGAVCMLLA-------------SKLRETTPLTIEKLCIYTDH 144


>pdb|1W98|B Chain B, The Structural Basis Of Cdk2 Activation By Cyclin E
          Length = 283

 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 14/94 (14%)

Query: 204 INPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNV-IIRQQLQLLGVACMMIS 262
           + P MRAIL+DWL+EV E Y+L  ET +LA ++ DRY++    +++  LQL+G++ + I+
Sbjct: 45  LQPKMRAILLDWLMEVCEVYKLHRETFYLAQDFFDRYMATQENVVKTLLQLIGISSLFIA 104

Query: 263 ATMDNKWKSDYVVSKYEEICPPQVEELCYITDNT 296
           A             K EEI PP++ +  Y+TD  
Sbjct: 105 A-------------KLEEIYPPKLHQFAYVTDGA 125


>pdb|1JOW|A Chain A, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
           Cyclin
 pdb|1XO2|A Chain A, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
           Complex With A Flavonol Inhibitor, Fisetin
 pdb|2EUF|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
           Inhibitor Pd0332991
 pdb|2F2C|A Chain A, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
           Aminopurvalanol
          Length = 254

 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 13/102 (12%)

Query: 192 PSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNVIIRQQL 251
           P    +  +Q ++    R IL+ W+  + E + L      L+V+ +DRYL      ++ L
Sbjct: 35  PKFTSLWEIQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCKKQGTKKTL 94

Query: 252 QLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYIT 293
           Q +G AC++I              SK   + P  V +L Y++
Sbjct: 95  QKIGAACVLIG-------------SKIRTVKPMTVSKLTYLS 123


>pdb|1BU2|A Chain A, X-Ray Structure Of A Viral Cyclin From Herpesvirus Saimiri
          Length = 229

 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 13/102 (12%)

Query: 192 PSLDFMDRVQKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNVIIRQQL 251
           P    +  +Q ++    R IL+ W+  + E + L      L+V+ +DRYL      ++ L
Sbjct: 14  PKFTSLWEIQTEVTVDNRTILLTWMHLLCESFELDKSVFPLSVSILDRYLCKKQGTKKTL 73

Query: 252 QLLGVACMMISATMDNKWKSDYVVSKYEEICPPQVEELCYIT 293
           Q +G AC++I              SK   + P  V +L Y++
Sbjct: 74  QKIGAACVLIG-------------SKIRTVKPMTVSKLTYLS 102


>pdb|1G3N|C Chain C, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
 pdb|1G3N|G Chain G, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
          Length = 257

 Score = 33.5 bits (75), Expect = 0.21,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 13/91 (14%)

Query: 201 QKDINPGMRAILIDWLVEVSEEYRLVPETLFLAVNYIDRYLSGNVIIRQQLQLLGVACMM 260
           Q+ +   MR +L  W+  V +EY L P  + LA+N +DR L    + ++  Q  G AC++
Sbjct: 43  QQSLTSHMRKLLGTWMFSVCQEYNLEPNVVALALNLLDRLLLIKQVSKEHFQKTGSACLL 102

Query: 261 ISATMDNKWKSDYVVSKYEEICPPQVEELCY 291
                        V SK   + P     LCY
Sbjct: 103 -------------VASKLRSLTPISTSSLCY 120


  Database: pdbaa
    Posted date:  Mar 3, 2013 10:34 PM
  Number of letters in database: 14,973,337
  Number of sequences in database:  62,578
  
Lambda     K      H
   0.322    0.135    0.408 

Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,384,764
Number of Sequences: 62578
Number of extensions: 327818
Number of successful extensions: 727
Number of sequences better than 100.0: 29
Number of HSP's better than 100.0 without gapping: 29
Number of HSP's successfully gapped in prelim test: 0
Number of HSP's that attempted gapping in prelim test: 648
Number of HSP's gapped (non-prelim): 30
length of query: 402
length of database: 14,973,337
effective HSP length: 101
effective length of query: 301
effective length of database: 8,652,959
effective search space: 2604540659
effective search space used: 2604540659
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 52 (24.6 bits)